Home  >  Products  >  EIF2B5 (eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa ) Blocking Peptide (the N terminal of EIF2B5)(100ug)
EIF2B5 (eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa ) Blocking Peptide (the N terminal of EIF2B5)(100ug)

EIF2B5 (eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa ) Blocking Peptide (the N terminal of EIF2B5)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-EIF2B5 Antibody (ARP61329_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61329
Size: 100ug
Weight: 79kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes one of five subunits of eukaryotic translation initiation factor 2B (EIF2B), a GTP exchange factor for eukaryotic initiation factor 2 and an essential regulator for protein synthesis. Mutations in this gene and the genes encoding other EIF2B subunits have been associated with leukoencephalopathy with vanishing white matter.
Alternative names: CACH; CLE; EIF-2B; EIF2Bepsilon; LVWM
See Full Product Listings >